Pricing Log in Create free account

Aurora Cannabis Inc. (ACB) vs Anika Therapeutics Inc. (ANIK)

Aurora Cannabis Inc. and Anika Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. and Anika Therapeutics Inc. are of similar size ($276.9M and $265.8M). Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against −18.2%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −38.1%) and the higher return on invested capital (−3.24% vs −5.58%). Across the 18 metrics below, Anika Therapeutics Inc. leads on 12 and Aurora Cannabis Inc. on 6.

Valuation

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 1.17 2.21 2.11
P/B 0.65 1.94 1.78
Price to free cash flow n/m 473.90 16.14
EV/EBITDA n/m 493.99 12.58
EV/Sales 0.93 2.10 2.73
Earnings yield (35.34%) (1.30%) (4.38%)
Free cash flow yield (14.67%) 0.21% 0.00%

Profitability

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 62.16% 53.94%
Operating margin (12.13%) (4.24%) 0.00%
Net margin (38.12%) (3.14%) 0.00%
Free cash flow margin (17.19%) 0.47% 0.00%
Return on equity (19.85%) (2.66%) (0.40%)
Return on assets (15.19%) (2.04%) (3.32%)
Return on invested capital (5.58%) (3.24%) 0.00%

Growth

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 5.33% 10.01%
EPS growth (last fiscal year) (5,266.67%) 80.16% 49.06%
Revenue growth, 5-year CAGR 3.92% (2.86%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.00 0.05
Current ratio 5.36 4.48 2.31
Net debt to EBITDA 5.11 10.80 0.97

Dividend

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Market cap 265.84m 276.90m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack